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1 These authors contributed equally to this work.Though genome-wide technologies, such as microarrays, are widely used, data from these methods are
considered noisy; there is still varied success in downstream biological validation. We report a method
that increases the likelihood of successfully validating microarray ﬁndings using real time RT-PCR,
including genes at low expression levels and with small differences. We use a Bayesian network to iden-
tify the most relevant sources of noise based on the successes and failures in validation for an initial set of
selected genes, and then improve our subsequent selection of genes for validation based on eliminating
these sources of noise. The network displays the signiﬁcant sources of noise in an experiment, and scores
the likelihood of validation for every gene. We show how the method can signiﬁcantly increase validation
success rates. In conclusion, in this study, we have successfully added a new automated step to determine
the contributory sources of noise that determine successful or unsuccessful downstream biological
validation.
 2008 Elsevier Inc. All rights reserved.1. Background
Genome-wide technologies such as gene expressionmicroarrays
offer the possibility of large-scale screening to ﬁnd new genes and
pathways involved in complex biological processes. However,
potentially, a lot of interesting ﬁndings are lost because of issues of
noise. A technique that identiﬁes the sources of noise to guide subse-
quent choices of genes to validate would improve genomic technol-
ogy. We describe such a general technique in this study.
The success of validating genes determined to be signiﬁcantly
involved in a process by using genomic technologies, such as gene
expression microarrays, is quite variable. Though there are dozens
of published methods to determine the most statistically signiﬁ-
cantly differentially expressed genes given two sets of microarray
data, the amplitude of difference does not necessarily correspond
with the likelihood of successful validation using a more sensitive
measurement technique such as quantitative real time reverse
transcriptase-polymerase chain reaction (RT-PCR). It is more com-
monly assumed that higher fold changes (greater than 2) are more
likely to validate with gold standard methods such as RT-PCR. This
assumption is based on previous work showing genes with thisll rights reserved.
h).level of fold change are most likely to validate on another micro-
array technology [1]. It is also assumed that genes with small
mRNA expression changes (under 2-fold) or low expression levels
as measured by microarrays validate less often, because of the in-
creased noise in these measurements [2]. Without a new approach,
we cannot predict which of these small fold changes are reproduc-
ible without validating all genes, which is not feasible. This is
unfortunate because interesting changes in biological systems
may be governed by genes showing small differences in expres-
sion, especially when measured in the context of complex tissues
consisting of many different cell types. In addition, many of the
most biologically interesting genes are expressed at the lowest lev-
els, such as transcription factors.
Our goal here is to consider the process of validation by RT-PCR,
and to model the success and failure of validation of a gene as a
variable independent from the degree of likelihood of a signiﬁcant
change in that gene. Our hypothesis was that a machine-learning
method can be used to learn which sources of noise weighted most
importantly in successful gene validation.
Failure of validation has been attributed to the multiple sources
of biological and technological noise present in these high-
throughput measurement systems. Potential sources of biological
noise include circadian and other inﬂuences present at the time
samples are acquired [3,4] and tissue complexity [5]. Sources of
technical noise include variability in scanning and high back-
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cDNA arrays [7]. As microarray generations advance, more genes
and transcripts are probed, but the speciﬁc probes designed to de-
tect the RNA may change, and this can introduce irreproducibility
of measurement [8]. Noise is also introduced when samples being
compared are measured on different platforms; previous studies
have shown varying degrees of reproducibility for samples mea-
sured on spotted cDNA and oligonucleotide microarrays [9].
In this work, we show how we tested our hypothesis by using
Bayesian networks, a method to model variables and the conditional
probabilities between them, to probabilistically model the likelihood
of successfulvalidation, given inputsourcesofnoise [10]. Bayesianap-
proacheshavebeenpreviouslyused atmanydifferent levels ofmicro-
array analysis. At the raw image level, Bayesian networks built using
pixel data have been used tomodel and improve the quality ofmicro-
array measurements [11]. At the processedmeasurement level, Baldi
and Long showed how a Bayesian t-test could be used on estimates of
distributions of gene expressionmeasurements, and showedhowthis
approach better compensates for lack of replicates [12]. Long, et al.,
then showed the success of this approach in an E. coli microarray
experiment [13]. Ibrahim, et al., used a similar approach,with the cru-
cial difference that a correlational structure between geneswasmod-
eled [14]. Broet, et al., used a hierarchical model taking into account
multiple discrete levels of gene expression change [15]. At the mul-
ti-gene level, Bayesian and other probabilistic networks havebeen in-
ferred frommicroarray data [16–20].
Ourmethod is different than themany previous uses of Bayesian
approaches, in that we are modeling the success and failure of vali-
dation as a variable dependent on multiple estimators of measure-
ment noise. It is important to note that we are not modeling theFig. 1. Schema used for the analysis. Microarray data was used to generate a list of sign
were validated by RT-PCR (2). The successes and failures for these genes as well as 22 ad
Bayesian network. This became our predictive model for future successful validation (4).
12 newly selected genes (5) and our success rate improved to 92%, despite these genes aclikelihood of a signiﬁcant change in a gene givenmultiple measure-
ments, nor are we building a Bayesian network of genes.
The model we describe in this paper was built and tested on
time-series measurements in the domain of diabetic retinopathy.
At the onset of the analysis of the microarray data in this biological
system, most of the observed differences in gene expression
between mice under normal oxygen and hyperoxia conditions
were small, possibly because the retina is a complex organ with
different cell types. Very few genes were found to be signiﬁcantly
different using established methods such as Signiﬁcance Analysis
of Microarrays (SAM) [21]. Of the genes chosen by signiﬁcance
using conventional t-tests, only 33% initially validated by RT-PCR
(examples shown in Fig. 3). Here, we show how we ﬁrst created
and trained a Bayesian network on the success and failures of these
genes. We then validated a new set of genes guided by the
network. The success rate of validation for the tested set of genes
improved to 92%. Interestingly, the genes in the test set showed
very small expression differences for the Affymetrix data; in most
cases less than 1.5-fold. In conclusion, we increased the likelihood
of selecting genes that are successfully validated by the introduc-
tion of an automated step after the traditional bioinformatics step
in microarray analyses.2. Methods
2.1. Microarray data
Mice were exposed to air containing a normal concentration of
oxygen, and hyperoxia, a process that parallels early stages ofiﬁcant gene expression changes using pair-wise t-test comparisons (1). These genes
ditional genes for which there was pre-existing RT-PCR data (3) were used to train a
Based on the predicted likelihood of validation, we performed RT-PCR validation on
tually performing worse on the speciﬁc t-test comparisons than the original set (6).
Fig. 2. Three sets of comparisons of biological interest.(1) Consecutive comparisons
(dashed lines). (2) Cross-condition comparisons (solid lines). Note: The 7H ?7N
comparison exists for Affymetrix data alone. (3) Baseline comparisons (dotted lines).
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day-7 (P7) C57Bl/6 mice with nursing mothers were exposed to
75% ± 2% oxygen for 12-h (P7 + 12-h), 24-h (P7–P8), 72-h (P7–
P10), or 120-h (P7–P12) periods in a sealed incubator. Age-
matched room-air mice (P7, P8, P10, and P12) were used as con-
trols. At each time point for both control and oxygen-treated mice,
we pooled retinas from 8 different mice of 8 different litters to re-
duce biologic variability. The entire RNA preparation process was
repeated three times at each of the four time points for both con-
trol and oxygen-treated groups, so that 24 RNA samples of 8
pooled retinas each were collected. RNA was hybridized to Affyme-
trix MOE3430Amicroarrays using established protocols. The image
ﬁles were analyzed with Microarray Suite 5.0 (MAS 5.0) software.
For each condition, we measured RNA at the time-points P7, P8,
P10 and P12 with biological triplicates for each time-point. Data
is available under accession GSE1816 at the National Center for
Biotechnology Information (NCBI) Gene Expression Omnibus.
2.2. RT-PCR
RNA was prepared for real time RT-PCR from different pools of
mice using the same methods as were used for microarray mea-
surements. The same time-points were used for both techniques
except for the P7 time-point under hyperoxia, which was not mea-
sured by RT-PCR. Both cDNA preparation and the quantitative real-
time RT-PCR were performed as described previously [23]. Brieﬂy,
100 ng of puriﬁed total RNA was reverse transcribed into cDNA
using murine leukemia virus reverse transcriptase and random
primed hexamer (Invitrogen, Bethesda, MD). The ABI Prism 7700
Sequence Detection System (Applied Biosystems) and the SYBR
Green master mix kit (Qiagen) were used for detecting real-time
RT-PCR products from 0.25–2.5 ng reverse transcribed cDNA sam-
ples. Cyclophilin-A, which exhibits a constant level in comparison
with 18S rRNA in the retina samples, was used as the normalizer.
PCR reactions for each sample were done in duplicate for target
genes and triplicate for precisely quantiﬁed and 10-fold serially
diluted cDNA templates. Copy numbers were determined from
the cDNA standard curves. The level of target gene expression
was calculated after normalizing against the 106 cyclophilin-A cop-
ies in each sample and data are presented as mRNA copies per 106
cyclophilin-A copies.
2.3. Algorithm
We ﬁrst used a conventional technique to determine lists of sig-
niﬁcantly differentially expressed genes for validation by real time
RT-PCR (Fig. 1). Many of these genes did not validate. A Bayesian
network was trained on the success and failure of RT-PCR valida-
tion of these and other genes, given the input of multiple charac-teristics of the genes. After the creation of the Bayesian network,
the network was then applied to a set of genes from the micro-
array, and a sample of genes were then chosen for RT-PCR based
on having the highest predicted likelihood of validation. Each of
these steps is described below.
2.4. Selection of candidate genes for the Bayesian network analysis
First, three sets of pair-wise comparisons of biological interest
were deﬁned (Fig. 2): (A) Consecutive comparisons, where consecu-
tive time-points are compared with each other in both the nor-
moxia and hyperoxia time series. (B) Cross-condition comparisons,
where each hyperoxia time-point is compared to its corresponding
normoxia time-point. (C) Baseline comparisons, where each of the
hyperoxia time-points are compared to the day 7 normoxia time-
point.
A list of genes signiﬁcantly different from each pair-wise com-
parison in each of these sets of comparisons was generated using
a two-tailed Student’s t-test with unpaired values with Welch cor-
rection for unequal variance [24], and selecting genes with p < 0.01,
similar to many previous studies [25,26]. Methods that compen-
sated for multiple-hypothesis testing, such as SAM, resulted in no
signiﬁcantly expressed genes in most comparisons [21]. Genes
were selected to be validated by RT-PCR because they were posi-
tive in at least one of the cross-condition and baseline comparisons
as shown in Table 2. Eighteen genes were initially validated by RT-
PCR. To this set, another 22 genes were added, for which there was
pre-existing RT-PCR data measured before the microarrays were
measured, bringing the total number to 40 genes used to train
the network.
2.5. Database used for induction of Bayesian network
Six input variables and six output variables were calculated for
each gene in the training set and were used to create the database
(Table 1). The six input variables were estimates of noise based on
the Affymetrix measurements and probe set characteristics. We
also included two output success (outcome) variables and four out-
put variables. The output success variables incorporate both
Affymetrix and RT-PCR data and deﬁne a successful RT-PCR valida-
tion of the Affymetrix data. The network is queried to predict these
two success variables. The other four output variables incorporate
only RT-PCR data. These four output variables were not predicted
using the Bayesian network and do not deﬁne a successful RT-
PCR validation. Though we call these variables output variables,
we actually have them as input during training, but they were
missing when the network was actually used in the test set. While
they are not crucial to the development of the network or the pre-
diction of the output success variables, we designed them into the
network to secondarily learn predictors for these RT-PCR variables
from the original microarray data. We also wanted to learn the rel-
ative input of the RT-PCR and Affymetrix data in the output success
variables.
The input variable Corr-Replic-Affy is the mean of three Pearson
correlation coefﬁcients calculated from the three possible pair-
wise pairings of triplicate vectors. These are from eight measure-
ments, four measurements in the normoxia time-series and four
measurements in the hyperoxia time-series. This variable is a mea-
sure of the strength of the linear relationship within replicates.
The input variable Unique-Affy-Probe assumes a ‘‘yes” value if
the probes in the Affymetrix probe set are unique for the measured
transcript (i.e. probe set identiﬁer ends with ‘‘_at”) and a ‘no’ value
if the probes are potentially shared between multiple transcripts of
the same or different genes (i.e. probe set identiﬁer ends with
‘‘_a_at” or ‘‘_s_at”) or probes for which the rules for cross-hybrid-
ization were dropped (i.e. ends with ‘‘_x_at”). We observed differ-
Fig. 3. Example of genes with successful and unsuccessful validation. (A) Pfkp is an example of a gene with high Consec-Dir-Match score (0.83) because the Affymetrix and
RT-PCR data have similar trends across both the normoxia and hyperoxia time series, even though by microarray the highest Consecutive comparison fold difference is only
1.6-fold. (B) Ak4 is an example of a gene with high Ampli-Cross-Condn-Match score (1.00), indicating that at corresponding time points, the difference between hyperoxia and
normoxia seen in the RT-PCR measurements was at least as high as that seen in the Affymetrix measurements; the highest fold difference in a Cross-condition comparison is
only 2.4-fold for the Affymetrix measurements. (C) Fish is an example of a gene that validated poorly and showed low scores for both output variables, despite having a higher
maximum Consecutive comparison fold difference (2.0-fold) and higher maximum Cross-condition comparison fold difference (2.5-fold) than the other two genes.
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and hypothesized that the type of probe set might inﬂuence the
success of validation and the output variables. The input variable
Mean-Affy was deﬁned as the mean expression level for a gene
across all time-points and replicates. The input variable Pcalls re-
ﬂects the count of the Present Detection calls as reported by the
Affymetrix MAS 5.0 software for each gene across all 24 micro-
arrays [27].The input variable Cross-Condn-Ttest-Affy reﬂects the count of
signiﬁcant t-tests in Cross-condition comparisons (as deﬁned ear-
lier), ranging from 0 to 4. The input variable Consec-Baseln-Ttest-
Affy indicates the count of signiﬁcant t-tests in Consecutive and
Baseline comparisons, ranging from 0 to 9. Corr-Replic-Rt, Mean-
Rt, Cross-Condn-Ttest-Rt, and Consec-Baseln-Ttest-Rt were exactly
similar to their corresponding input variables, except calculated
using the RT-PCR measurements.
Table 1
Variables used to train the Bayesian network
Variables (for each gene) Deﬁnition
Input Variables
Pcalls Number of ‘‘Present” detection calls
Unique-Affy-Probe Type of microarray probe
Corr-Replic-Affy Mean pair-wise triplicate correlation
Consec-Baseln-Ttest-Affy Number of signiﬁcant Consecutive and Baseline comparison t-tests
Cross-Condn-Ttest-Affy Number of signiﬁcant Cross-condition t-tests
Mean-Affy Mean signal across all 24 microarrays
Output Variables
Corr-Replic-Rt Within duplicate correlation
Consec-Baseln-Ttest-Rt Number of signiﬁcant Consecutive and Baseline comparison t-tests
Cross-Condn-Ttest-Rt Number of signiﬁcant Cross-condition t-tests
Mean-Rt Mean expression level
Output Success Variables
Consec-Dir-Match RT-PCR measurements successfully validated the direction (increased or decreased) of change
Ampli-Cross-Condn-Match RT-PCR measurements successfully validated the fold changes across conditions
Six input variables, four output variables, and two output success variables were used to train the Bayesian network. Details of these variables are explained in the text.
Table 2
Number of genes with signiﬁcant t-tests for one or more of the deﬁned biologically
interesting comparisons
Number of genes with a
positive t-test for one or
more of the Cross-condition
comparisons
Number of genes with a
positive t-test for one or
more of the Baseline
comparisons
Before Network 15/18 (83%) 3/18 (17%)
After Network 8/12 (67%) None
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used as output success variables on which the Bayesian network
was queried to predict. These were as follows:
2.5.1. Consec-Dir-Match
In order to deﬁne whether the Affymetrix and RT-PCR data
showed similar patterns for the normoxia and hyperoxia time ser-
ies, we considered the set of Consecutive comparisons in Fig. 2.
Biologically, these comparisons are an indicator of change in
expression level for a gene between time points in the normal
and hyperoxia conditions. Each of the above comparisons was as-
signed a 1 if the Affymetrix and RT-PCR fold changes were in the
same direction (increased or decreased expression) and zero
other-wise. The average of the six was called the Consec-Dir-Match
variable and ranged between 0 and 1. A Consec-Dir-Match value of
greater than 0.5 was deﬁned as a success.
2.5.2. Ampli-Cross-Condn-Match
Because we were primarily interested in the effects of hyper-
oxia on each gene at each time-point, Cross-condition comparisons
were also considered informative. A fold ratio for a gene was com-
puted by taking the arithmetic mean of replicate expression mea-
surements for that gene under hyperoxia and normoxia at a given
time point and dividing the means. Each of the 3 Cross-condition
comparisons was assigned a 1 if the fold ratio calculated using
the RT-PCR measurements was equal or higher in magnitude than
the fold ratio calculated using the Affymetrix measurements, and
greater than a minimum relevance threshold of 1.4-fold; otherwise
a zero was assigned. The average over the three fold changes is a
factor between 0 and 1 and deﬁnes the Ampli-Cross-Condn-Match
variable. An Ampli-Cross-Condn-Match variable value of greater
than 0.5 was deﬁned as a success. The training data set is available
as Supplemental Table 1: english supplemental table 1.xls.
Regarding the threshold, it does not make sense to employ a
threshold of less than 0.5 for either of the success variables, as that
would mean that less than half of the comparisons met the successcriteria. For both success variables, if the threshold (ranging from 0
to a maximum value of 1) is plotted against performance, the trend
of performance versus threshold is increasing. As a result, a thresh-
old of 0.5 is a reasonable and conservative pick. The performance is
deﬁned as the improvement in the success rate of the test set com-
pared to the initial set of 18 genes picked on bioinformatics criteria
that formed part of the training set.
2.6. Statistical modeling of the Bayesian network
This database of variables (Supplemental Table 1) was then used
to create the structure of and ascertain the distributions for the
Bayesian network. This was done using Bayesware Discoverer, which
explores a working subset of models as deﬁned by the user by iden-
tifyinganorderwithwhich thevariables in thedatabasewill beeval-
uated [28]. The higher the assigned rank of a variable, the greater the
number of other variables that will be tested as potential precedent
variables; thus, output success variables were placed at the highest
rank. The threshold Bayes factor was set at 3, a conservative value
that reduces false positives. No limitwas put on themaximumnum-
ber of parents (precedent variables) that a variable can have. The
Prior Precision, encoding the conﬁdence of prior distributions, was
set at thedefault valueof1. As theconstructionofBayesiannetworks
is markedly difﬁcult when handling continuous variables, all vari-
ables were discretized. Inmost cases, the continuous variableswere
discretized into two bins of equal length by taking the range of val-
ues, and creating two bins using the midpoint of the range. In the
case of Cross-Condn-Ttest-Affy, three bins were used.
After the Bayesian network was created using the training data,
a set of the genes measured on the microarrays was evaluated
using the network. We identiﬁed a set of Affymetrix probe-sets
whose expression values across time-points correlated to one or
more of ﬁve markers of endothelial cells with a Pearson correlation
coefﬁcient of greater than 0.8. The 5 genes used as markers were
ICAM-1, PECAM-1, Tie-1, Tie-2 and VE-cadherin. The number of
probe-sets correlating to each of these markers ranged from 220
to 450. The network was used to predict which of these genes were
likely to successfully validate by RT-PCR. Based on the predicted
high likelihood of validation in the two output success variables
Consec-Dir-Match and Ampli-Cross-Condn-Match, a sample of 12
genes was selected to test the network. Signiﬁcance in the differ-
ence in validation success rates was determined using a v2 test
in Microsoft Excel 2002 (Redmond, Washington). The test data
set is available as Supplemental Table 2: english supplemental ta-
ble 2.xls.
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3.1. Training and testing the network
Our goal was to develop an automated method to predict which
genes implicated in an experiment using microarray measure-
ments would be most likely to successfully validate by RT-PCR,
trained using the experience from a starting set of genes that suc-
cessfully and unsuccessfully passed validation. To improve our
ability to generalize ﬁndings, the training set consisted of two sets
of genes. We initially attempted validation of 18 genes chosen on
the basis of the statistically signiﬁcant differences between com-
parison groups, as deﬁned by t-tests. This set of 18 genes became
the training set. To add data on genes failing validation, we then
added another 22 genes to the training set for which there was
pre-existing RT-PCR data performed under the same biological
conditions, along with the microarray data acquired after the RT-
PCR measurements. We gauged the success and failure of this val-
idation and calculated estimates representing potential sources of
noise. These inputs were used to create and train a Bayesian net-
work. Two output success variables, Consec-Dir-Match and Ampli-
Cross-Condn-Match were deﬁned for the successful validation of
Affymetrix microarray data by RT-PCR, using strict criteria. Success
using the Consec-Dir-Match variable identiﬁes genes that show
similar patterns of expression across the time series for microarray
and RT-PCR data. Success using Ampli-Cross-Condn-Match, which
identiﬁes genes with expression differences between correspond-
ing normoxia/hyperoxia time-points that can be validated, was
the most relevant to the biological question being asked. Of the ini-
tial set of 18 genes, selected using t-tests, the rate of genes with
successful Ampli-Cross-Condn-Match was only 33% and the rate of
genes with successful Consec-Dir-Match was 50%. Of the additionalFig. 4. Topology of the identiﬁed Bayesian network. The identiﬁed Bayesian network cons
variables. The six input variables (black text on white) reﬂect calculated indications of b
(black text on gray) indicate similar calculations made using the RT-PCR measurements. T
biological validation (as strictly deﬁned in the text). Dependencies can be positively (pl
Bayes factor between the given set of parent dependencies (i.e. the most probable) and n
the set of four parent dependencies into the Ampli-Cross-Condn-Match variable is 7176 ti
factor between the given set of parent dependencies and the set without the annotated d
three parent dependencies into Ampli-Cross-Condn-Match improves the likelihood of exp
Corr-Replic-Affy, which measures the intra-replicate correlation between gene measurem
strongest in conditioning both output success variables.22 genes, only one had a successful Ampli-Cross-Condn-Match
(4.5%). In the full training set, there were 17% of genes with suc-
cessful Ampli-Cross-Condn-Match and 57% of genes with successful
Consec-Dir-Match. Fig. 3 shows examples from the training set of
genes that served as successfully and unsuccessfully validated
genes.
3.2. Results from the Bayesian network
After extracting the network from the data (Fig. 4), we applied it
to a set of genes on the microarray. The retina is a complex organ
made up of different kinds of cells, of which endothelial cells are a
small proportion. Under conditions of hyperoxia, the endothelial
cells undergo vaso-obliteration and thus are likely to show genes
changes between normoxia and hyperoxia. These gene changes
are likely very small as the whole retina was used in the experi-
ment. It was of interest to identify potential novel endothelial cell
genes that showed expression differences between normoxia and
hyperoxia conditions that could be validated by RT-PCR. Towards
this end, we applied the network to a set of genes whose mean
expression values correlated to one or more of ﬁve known markers
of endothelial cells. Running the genes through the network iden-
tiﬁes genes that are more likely to meet our criteria for successful
validation by RT-PCR. And as genes from other cell types would
also show gene changes between normoxia and hyperoxia condi-
tions, restricting to genes that show a correlation with known
markers of endothelial cells may be more likely to identify genes
potentially expressed in endothelial cells.
We picked a set of 12 genes to validate out of the genes most
likely to have a successful Consec-Dir-Match and Ampli-Cross-
Condn-Match, our strict deﬁnitions of biological validation. The dis-
tributions of microarray measurements for the entire set of genes,ists of nodes (variables) connected by signiﬁcant conditional dependencies between
iological or technical noise in microarray measurements. The four output variables
he two output success variables (white text on black) reﬂect the event of successful
us sign) or negatively (minus sign) correlated. Numbers within nodes indicate the
o parent dependencies. For example, as a model explaining the given training data,
mes more likely than no parent dependency. Numbers on arrows indicate the Bayes
ependency. For example, adding the Corr-Replic-Affy parent dependency to the other
laining the output variable by 10,982-fold. The interpretation of this network is that
ents by microarray, is the most informative input variable in the network in that it is
Table 3
RT-PCR validation rates of genes selected without and with the network
Number of genes with a
Consec-Dir-Match > 0.5
Number of genes with an
Ampli-Cross-Condn-Match > 0.5
Before Network 9/18 (50%) 6/18 (33%)
After Network 8/12 (67%) 11/12 (92%)
The success rates without the network are for the set of 18 genes which later
formed part of the training data for the network.
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ANOVA (p = 0.09). We found that performing RT-PCR on genes
where the Bayesian network predicted successful validation
resulted in a signiﬁcant improvement in the rate of successful val-
idation (Table 3). Compared to the results from our initial set of
genes selected on bioinformatics criteria, the rate of genes with
Consec-Dir-Match improved from 50% to 67%, and for Ampli-Cross-
Condn-Match, the rate improved signiﬁcantly from 33% to 92%
(v2 p = 0.000005). Of note, the genes chosen for the test set actually
score more poorly than the original set of genes based on the
traditional bioinformatics criteria (Table 2) suggesting that in this
experiment, successful validation is governed more by choosing
genes with less noisy measurements than by choosing genes based
on statistical signiﬁcance.
The goal of Bayesian network extraction is to ﬁnd the model
with the maximum marginal log-likelihood compared to the next
most probable model given the data. The marginal log-likelihood
of the entire network is the sum of the marginal log-likelihood of
each dependency. In order to do this, for each variable, we ﬁnd
the most probable parent dependencies given the data. The mar-
ginal log-likelihood of each variable is used to compute the Bayes
factor. For a given variable, the Bayes factor is computed as a ratio
between the most probable dependency and other sets of depen-
dencies, including the null hypothesis of no dependence. The Bayes
factor serves as a measure of how many times more probable is
one dependency compared to another.
Our resultant Bayesian network (Fig. 4) identiﬁed a single most
informative variable, Corr-Replic-Affy, which measures the strength
of the linear relationship within replicates using the Pearson corre-
lation coefﬁcient. Both output success variables conditionally
depend on Corr-Replic-Affy. The likelihood of Consec-Dir-Match
and Ampli-Cross-Condn-Match explaining the output variable
increased 17- and 10,982-fold, respectively, after the addition of
Corr-Replic-Affy as a parent dependency. In addition, these were
positive correlations, in that a higher value for this variable, indic-
ative of stronger correlation between the triplicate measurements
by microarray, was associated with greater likelihood of validation
by RT-PCR. We used this variable as the primary basis for selecting
genes for the test set, for further validation.
Besides Corr-Replic-Affy, the only other input variable condition-
ing Ampli-Cross-Condn-Match is Consec-Baseln-Ttest-Affy. The rela-
tionship is positive, in that the greater the number of signiﬁcant
comparisons for a gene, the greater the likelihood of a positive
match for that gene, but weaker than Corr-Replic-Affy. The output
variables Corr-Replic-Rt and Cross-Condn-Ttest-Rt also condition
Ampli-Cross-Condn-Match.
Other than Corr-Replic-Affy, the other variable that conditions
Consec-Dir-Match is Mean-Affy, which represents the mean expres-
sion level across all time-points as measured by the microarrays.
Speciﬁcally, for genes with high Corr-Replic-Affy, if the mean
expression measurements are high (in this experiment, above
5600 arbitrary Affymetrix units), the likelihood of Consec-Dir-
Match is 90.0%, compared to 99.3% if the mean expression levels
are lower. For genes with low Corr-Replic-Affy, the likelihood of
Consec-Dir-Match is 80.6% if the mean expression level is low,
which drops to only 5.6% if the mean expression level is high. Thisis a surprising result, as genes at higher expression levels are com-
monly considered as being measured with less noise. But Mean-
Affy is a weaker parent variable for Consec-Dir-Match than Corr-
Replic-Affy, as indicated by the fact that adding the Mean-Affy
dependency improves the likelihood of explaining Consec-Dir-
Match only by 4 as compared to 17-fold for Corr-Replic-Affy.
Another unexpected relation was seen in that Consec-Baseln-
Ttest-Affy conditions Corr-Replic-Rt, but this relationship is nega-
tive. In other words, the greater the number of signiﬁcant compar-
isons for a gene, the lower the likelihood of a high correlation
between replicates, as measured by RT-PCR.
As expected, the input variableMean-Affy conditions the output
variable Mean-Rt. Mean-Affy and Mean-Rt are the mean expression
measurements across all time-points for a single gene as measured
by Affymetrix microarray and RT-PCR respectively. It is encourag-
ing that there is a direct relationship between the two variables,
and this can serve as a positive control.
The four non-success output variables also provide useful infor-
mation to the experimentalist. For example, it is informative that
correlation between RT-PCR replicates as well as signiﬁcant t-tests
for RT-PCR both contribute to a successful RT-PCR validation of
Affymetrix data. It is also informative that none of the Affymetrix
nodes points to Cross-Condn-Ttest-Rt, while this is not the case
for Corr-Replic-Rt.
Finally, the orphaned input and output variables, whose distri-
butions neither condition nor are conditioned by any other vari-
ables, also provide information. These variables include Pcalls,
Unique-Affy-Probe, and Consec-Baseln-Ttest-Rt. In other words, the
type of probe set and the number of Detection calls as reported
by the Affymetrix MAS 5.0 software did not signiﬁcantly inﬂuence
the likelihood of a successful validation.
4. Discussion
Using Bayesian networks, we were successful in our goal of cre-
ating an automated method that can determine which factors con-
tribute most signiﬁcantly to the successful RT-PCR validation of
genes implicated from microarray measurements. We trained a
Bayesian network on the successes and failures of an initial set of
genes using input sources of noise. This helped us identify predic-
tors of successful validation that we did not know of a priori. Sig-
niﬁcantly, the Bayesian network can allow for the successful
validation of genes that show small fold changes, such as one
shown in Fig. 3A; many biologically interesting genes are in this
category. Of the successfully validated genes in our test set, most
showedmicroarray data fold changes of less than 1.5-fold. The net-
work can also allow for the validation of genes that show low
expression levels.
With the Bayesian network created on our preliminary experi-
mental data, we determined that optimizing the selection of genes
based on ‘‘within gene” correlation of microarray measurements
would most greatly improve our rate of biological validation, as de-
ﬁned by equal or greater fold-changes by RT-PCR between hyper-
oxia and normoxia at each time point than by microarray. We
have shown that optimizing ‘‘within gene” correlation in the sub-
sequent selection of genes allowed us to signiﬁcantly increase rates
of validation, as the model predicted.
When used to boost validation rates in this experiment, the net-
work provided few results that were counter-intuitive. The inverse
relationship between a gene’s mean expression level across all
microarrays (Mean-Affy) and the likelihood of validation (Consec-
Dir-Match) is unexpected, as genes at higher expression levels are
thought to have measures that are less inﬂuenced by technical
noise. In actuality, gene expression differences between time
points in both conditions were less likely to be reproducible when
mean gene expression was higher, even when only the direction of
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within replicate RT-PCR measurements (Corr-Replic-Rt) drops
slightly as the number of signiﬁcant Base-line and Consecutive
comparisons for that gene increases (Consec-Baseln-Ttest-Affy),
though this relation is relatively weak (evidenced by the Bayes Fac-
tor of only 5 as compared to no relationship existing). Further
interpretation of these unexpected relations is limited by the size
of the training set of genes.
Use of the Bayesian network successfully allowedus to ﬁnd those
variables, representing sources of noise, thatwhen optimizedwould
allow a greater rate of validation. However, the lack of connections
betweenvariableswasalso illuminating. For example, the likelihood
of validatingadifferencebetweenhyperoxiaandnormoxiaandﬁnd-
ing an increased fold-change (Ampli-Cross-Condn-Match) was not
conditioned on the number of ‘‘Present” Detection calls (Pcalls), or
the mean expression level (Mean-Affy). Intuitively, without the net-
work,wewouldhaveconsideredchoosinggeneswithhigherexpres-
sion levels or withmany ‘‘Present” calls, as recommended by others
[29].With thenetwork,we instead foundanalternatevariable (Corr-
Replic-Affy) to optimize that would yield a higher rate of validation.
Although a high correlation between replicates was the best
predictor of success for this particular experiment, we are not
making the case that correlation within replicates will be the best
predictor for another experiment. We are making the case that it is
possible to statistically learn from failures in validation and
improve choices midstream within an experiment.
The approach that we used has some limitations. We recognize
that there are many more potential sources of noise those dis-
cussed here, but for the purposes of the present paper we have only
discussed a few. For example, our approach could be improved by
adding variables representing the distribution of raw intensities
over each probe pair of every probe set. Another useful variable
might be the number of probes that match sequences in the NCBI
Reference Sequence (RefSeq) database, as this can implicate the
validity of expression measurements [30]. We acknowledge that
over-ﬁtting may be a serious issue as not every gene was validated
using RT-PCR, and only a small sample of genes was used to train
and test the network. It is also true that we cannot completely dis-
count the possibility of an introduced bias based on the selection of
the test set. However, two separate issues are involved (1) identi-
fying gene changes that are relevant to the experimentalist and (2)
identifying reproducible (veriﬁable) gene changes. The methods
used to select genes for the training and the test sets both target
relevant gene changes. The second issue, the reproducibility of
gene changes, is dependent on noise factors. Another factor is that
straight discretization by range may oversimplify the complex dis-
tributions of each variable. In addition, our initial bioinformatics
criteria of selecting genes by count of signiﬁcant t-tests may ap-
pear naïve when alternate methods are available, including meth-
ods involving permutation testing, such as SAM [21]. However,
using SAM we obtained no signiﬁcantly changed genes at the ear-
lier time-points, possibly because of the smaller number of repli-
cates. As our goal was to increase the number of true positives
that successfully validate by a gold-standard method such as RT-
PCR, the technique used to identify signiﬁcantly changed genes is
less critical. Finally, we also acknowledge that our results may
not be generalizable to other platforms and analysis methods other
than differential expression. However, whichever the platform
used for a microarray study, there will be noise factors that nega-
tively affect the reproducibility of the data. And learning these
sources of noise and using the knowledge to guide further choices
for validation might be expected to improve the reproducibility.
In spite of the above limitations, we suggest that our method
can improve the optimization of countless other parameters which
are not presently used or weighted highly by existing bioinformat-
ics methods.5. Conclusions
This approach represents an improvement in the standardmeth-
odologyof genomicexploration. Basedonour results,we suggest the
addition of a new automated step to determine the contributory
sources of noise that determine a successful or unsuccessful RT-
PCRvalidation, andwesuggest takingadvantageof this stepmidway
through thevalidationof anyexperimentguidedbymicroarraydata.
This process can be tailored to different experiments and conditions
in other biological systems. Though we used Bayesian networks as
our automated prediction step, other supervised learning methods
can be used as well, such as support vector machines or decision
trees [31,32]. If output variables are carefully crafted to match ones
own deﬁnition of a successful validation, the resultant networkmay
signiﬁcantly improve validation efforts.
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